skip to Main Content

Study shows huge effect of obesity on pancreatic cancer development

Study shows huge effect of obesity on pancreatic cancer development
Pancreatic cancer is expected to become the second-deadliest cancer in the United States by 2030, driven in part by rising obesity rates. A new study led by Yale Cancer Center (YCC) researchers has demonstrated in mice that hormones released from the pancreas itself can advance pancreatic cancer -; and that weight loss can stop this process in its early stages. The research was published today in the journal Cell.

“These discoveries raise the hope of finding new ways to prevent both the growth and the spread of pancreatic cancer,” said Mandar Muzumdar, M.D., assistant professor of genetics at Yale School of Medicine, a member of the Yale Cancer Biology Institute, and senior author of the paper. Read more . . . 


Back To Top